 Connection
M Cave to Drug Resistance, Microbial
This is a "connection" page, showing publications M Cave has written about Drug Resistance, Microbial.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.054 |
|
|
|
-
Cave MD, Eisenach KD, Templeton G, Salfinger M, Mazurek G, Bates JH, Crawford JT. Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol. 1994 Jan; 32(1):262-6.
Score: 0.029
-
Hellyer TJ, DesJardin LE, Hehman GL, Cave MD, Eisenach KD. Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis. J Clin Microbiol. 1999 Feb; 37(2):290-5.
Score: 0.010
-
Nolan CM, Williams DL, Cave MD, Eisenach KD, el-Hajj H, Hooton TM, Thompson RL, Goldberg SV. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med. 1995 Sep; 152(3):1067-71.
Score: 0.008
-
Plikaytis BB, Crawford JT, Woodley CL, Butler WR, Eisenach KD, Cave MD, Shinnick TM. Rapid, amplification-based fingerprinting of Mycobacterium tuberculosis. J Gen Microbiol. 1993 Jul; 139(7):1537-42.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|